Symetis (Switzerland) a clinical-stage medical device company focused on percutaneous valve replacements, closed a $21.2M Series B financing. Participants include Wellington Partners, Vinci Capital–Renaissance, Banexi Venture Partners, Truffle Capital, Novartis Venture Fund, Aravis Venture and BioMedInvest.